Abstract: Techniques are disclosed relating to level-shifting circuitry and time borrowing across voltage domains. In disclosed embodiments, an apparatus includes pulse circuitry, latch circuitry, pull circuitry, and feedback circuitry. The pulse circuitry is configured to generate a pulse signal in response to an active clock edge. The latch circuitry is configured to store a value of an input signal, where the input signal has a first voltage level. The pull circuitry is configured to drive, during the pulse signal, an output of the latch circuitry to match a logical value of the input signal at a second, different voltage level. This may allow the input signal to change during the pulse, enabling time borrowing. The feedback circuitry is configured to maintain the output of the latch circuitry at the second voltage level after the pulse signal.

Abstract: Embodiments of the present disclosure disclose a secure communication method for a mobile terminal and a mobile terminal. The secure communication method may include: when a wireless communication connection is established between the mobile terminal and another mobile terminal, and the wireless communication connection meets a preset security processing trigger condition, prohibiting, by means of setting, a program in a common virtual kernel from accessing a shared memory between a secure virtual kernel and the common virtual kernel and accessing a peripheral that needs to be called for the wireless communication connection; performing, by using the secure virtual kernel, preset policy-based processing on communication content corresponding to the wireless communication connection; and outputting, by using the secure virtual kernel, communication content obtained by performing the preset policy-based processing.

Abstract: Various embodiments disclosed relate to novel methods of fabricating 3-D Li ion batteries using direct nanoimprint lithography. The present invention includes methods of fabricating high surface area electrodes, including imprint patterning of high aspect ratio parallel grating style electrodes. The method includes coating a substrate with an ink containing nanoparticles and subsequently annealing the ink into a desired pattern.

Abstract: Techniques are disclosed relating to level-shifting circuitry and time borrowing across voltage domains. In disclosed embodiments, an apparatus includes pulse circuitry, latch circuitry, pull circuitry, and feedback circuitry. The pulse circuitry is configured to generate a pulse signal in response to an active clock edge. The latch circuitry is configured to store a value of an input signal, where the input signal has a first voltage level. The pull circuitry is configured to drive, during the pulse signal, an output of the latch circuitry to match a logical value of the input signal at a second, different voltage level. This may allow the input signal to change during the pulse, enabling time borrowing. The feedback circuitry is configured to maintain the output of the latch circuitry at the second voltage level after the pulse signal.

Abstract: A secure interaction method includes receiving, by a processor, a secure processing request sent by an application program, where the application program operates in a normal mode, and the processor operates in the normal mode when receiving the secure processing request, switching, by the processor, from the normal mode to a secure mode according to the secure processing request, reading, by the processor operating in the secure mode, data information into a memory operating in the secure mode, where the data information is data that the processor operating in the secure mode generates after parsing the secure processing request, and controlling, by the processor operating in the secure mode, an accessed device to operate according to the data information stored in the memory operating in the secure mode.

Abstract: A transformer is disclosed. The transformer includes a first coil including a first stack of wire disks stacked in a first direction; an exterior barrier arranged to form a first air gap between outer sides of the wire disks of the first stack of wire disks and the exterior barrier; an interior barrier arranged to form a second air gap between inner sides of the wire disks of the first stack of wire disks and the interior barrier; a wind generator arranged to generate an air flow in the first direction; a core in the form of a cylinder that is surrounded by the first coil; and an air guiding plate fixed to one of the exterior barrier and the interior barrier, to guide the air flow in a second direction along first stack gaps between the wire disks of the first stack of wire disks. The transformer effectively improves the heat dissipation of the coil and thus allows a smaller transformer in size.

Abstract: Embodiments of the present disclosure disclose a secure communication method for a mobile terminal and a mobile terminal. The secure communication method may include: when a wireless communication connection is established between the mobile terminal and another mobile terminal, and the wireless communication connection meets a preset security processing trigger condition, prohibiting, by means of setting, a program in a common virtual kernel from accessing a shared memory between a secure virtual kernel and the common virtual kernel and accessing a peripheral that needs to be called for the wireless communication connection; performing, by using the secure virtual kernel, preset policy-based processing on communication content corresponding to the wireless communication connection; and outputting, by using the secure virtual kernel, communication content obtained by performing the preset policy-based processing.

Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract: A secure interaction method includes receiving, by a processor, a secure processing request sent by an application program, where the application program operates in a normal mode, and the processor operates in the normal mode when receiving the secure processing request, switching, by the processor, from the normal mode to a secure mode according to the secure processing request, reading, by the processor operating in the secure mode, data information into a memory operating in the secure mode, where the data information is data that the processor operating in the secure mode generates after parsing the secure processing request, and controlling, by the processor operating in the secure mode, an accessed device to operate according to the data information stored in the memory operating in the secure mode.

Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compound and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract: Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.